MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submited by kickingbird at Jun, 16, 2006 16:18 PM from Medical News Today
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the company´s live, attenuated vaccinetechnology. [click link for full article]
See Also:
Latest news in those days:
- USCDC Confirms Human Cases of H5 Bird Flu Among Colorado Poultry Workers 10 hours ago
- GISAID: H5N1 Bird Flu Circulating in Dairy Cows in the United States 19 hours ago
- USCDC: Colorado Reports Three Presumptive Positive H5 Cases in Poultry Workers 3 days ago
- USCDC: A(H5N1) Bird Flu Response Update, July 12, 2024 4 days ago
- Avian flu: increased vigilance recommended 5 days ago
[Go Top] [Close Window]